Next report date
Report period
Q2 2024
EPS estimate
—
Revenue estimate
—
17.41 MCNY
496.12 MCNY
346.95 M
Om CHENGDU OLYMVAX BIOPHARMACEUTICALS
Sektor
Bransch
VD
Shao Wen Fan
Webbplats
Huvudkvarter
Chengdu
Grundat
2009
ISIN
CNE1000051H8
FIGI
BBG00VSF0M44
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
